SCHEMBL19083008

SCHEMBL19083008

c1ccc2c(c1)oc1ccc(-c3ccc(-c4ccc(-c5ccc6oc7ccccc7c6n5)nc4)cn3)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
LIMK1 P53667 1/20 0.40
MAPT P10636 5/20 0.37
ALDH1A1 P00352 6/20 0.36
NPC1 O15118 5/20 0.36
HPGD P15428 4/20 0.36
LMNA P02545 4/20 0.36
RAB9A P51151 4/20 0.36
TDP1 Q9NUW8 2/20 0.36
KDM4E B2RXH2 5/20 0.35
HSD17B10 Q99714 2/20 0.35
TSHR P16473 1/20 0.35
CASP3 P42574 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
PPARG P37231 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986282 0.83 KDM4E (0.48) MEN1KMT2ASMN1; SMN2LIMK1MAPT
SCHEMBL15696821 0.83 KDM4E (0.48) MEN1KMT2ASMN1; SMN2LIMK1MAPT
SCHEMBL25461163 0.82 GRM4 (0.51) SMN1; SMN2LIMK1MAPTNPC1RAB9A
SCHEMBL15695186 0.80 CLK4 (0.44) MEN1KMT2ASMN1; SMN2LIMK1MAPT
SCHEMBL25461648 0.79 NPC1 (0.40) MEN1KMT2ASMN1; SMN2LIMK1MAPT
SCHEMBL7845838 0.78 KMT2A (0.44) MEN1KMT2ASMN1; SMN2LIMK1MAPT
SCHEMBL25461643 0.76 GRM4 (0.45) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL25461645 0.76 GRM4 (0.56) MEN1KMT2AMAPTNPC1LMNA
SCHEMBL25461644 0.76 GRM4 (0.56) MEN1KMT2ASMN1; SMN2LIMK1MAPT
SCHEMBL25461165 0.76 RAB9A (0.54) MEN1KMT2ASMN1; SMN2LIMK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200255-B1 ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY, AND LIGHTING DEVICE MERCK PATENT GMBH (DE) 2023-05-10 EP disclosed
US-10483471-B2 Organic electroluminescent element, method for producing organic electroluminescent element, display, and lighting device Konica Minolta, Inc. (JP) 2019-11-19 US disclosed
EP-3200255-A2 ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY, AND LIGHTING DEVICE Konica Minolta, Inc. (JP) 2017-08-02 EP disclosed
US-20170194574-A1 Organic Electroluminescent Element, Method For Producing Organic Electroluminescent Element, Display, And Lighting Device MERCK PATENT GMBH (DE) 2017-07-06 US disclosed
US-20170194574-A1 Organic Electroluminescent Element, Method For Producing Organic Electroluminescent Element, Display, And Lighting Device MERCK PATENT GMBH (DE) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10483471-B2 Organic electroluminescent element, method for producing organic electroluminescent element, display, and lighting device ELOVL5, ELOVL1, LAGE3 MEN1 2562/4885KMT2A 3536/4885SMN1; SMN2 1476/4885
US-20170194574-A1 Organic Electroluminescent Element, Method For Producing Organic Electroluminescent Element, Display, And Lighting Device ELOVL5, ELOVL1, LAGE3 MEN1 2562/4885KMT2A 3536/4885SMN1; SMN2 1476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.